<DOC>
	<DOCNO>NCT01510054</DOCNO>
	<brief_summary>MiRNAs single-stranded small non-coding RNAs act specific mRNAs regulate gene expression . Studies suggest miRNAs influence cellular activity uterus , include cell differentiation embryo implantation . In assisted reproductive cycle , control ovarian stimulation ( COS ) result supraphysiological steroid level associate low luteinizing hormone concentration luteal phase , peri-implantation implantation period . Luteal phase support , administration medication aim support implantation process , routine practice vitro fertilization ( IVF ) clinic . Luteal phase support steroid hormone find improve pregnancy rate human menopausal gonadotropin use conjunction GnRH agonists ovarian stimulation IVF . Reports effect steroid supplementation GnRH antagonist protocol limit . The propose project extension previous study Endometrial Luteal Phase Characteristics Luteal Phase Support Controlled Ovarian Hyperstimulation Protocols Gonadotropin Releasing Hormone Antagonists . The significance study base importance luteal phase endometrial COS process implantation . The availability oocycte donor assist reproduction technology program offer unique opportunity study impact different stimulation protocol quality luteal phase . In addition , oocyte donor model may allow u evaluate impact different luteal support protocol directly endometrial preparation histological well biochemical marker . Study design : Study subject underwent ovarian stimulation accord gonadotropin/GnRH antagonist protocol . All donor baseline measurement serum follicle stimulate hormone ( FSH ) estradiol level second day menstrual cycle . Provided serum FSH level less 10mIU/ml E2 level less 60pg/ml , ovarian stimulation initiate recombinant FSH . The daily dose adjust accord follicular development serial transvaginal ultrasound serum E2 response . A daily evening dose ganirelix acetate initiate 6th day stimulation continue day human chorionic gonadotropin administration . When least three follicle reach mean diameter 18mm , ovulation trigger single dose Human chorionic gonadotropin ( hCG ) . Sonographically guide transvaginal oocyte retrieval perform 34-36 hour hCG administration . Thirty endometrial biopsy oocyte donor COS cycle use study . Study subject randomize 4 group . Grp 1 : day retrieval , receive luteal-phase support , serve base line ; grp2 : 3 , 5 10 day retrieval luteal phase support , serve control ; grp3 : 3 , 5 10 day retrieval , luteal phase support progesterone form vaginal suppository start day retrieval ; grp4 : daily oral dose 2 mg 17β-estradiol addition micronized progesterone . Immediately endometrial biopsy specimen store liquid nitrogen tank -196°C . Total RNA isolate microarray perform use Illumina miRNA expression panel . Array result compile analyzed focusing follow aspect : target gene prominent miRNAs , miRNA profile relation target gene pathway ; miRNA expression profile relation endometrial dating status ; effect luteal phase support miRNA expression ovarian stimulation . Minimum 3 miRNA array run sample purpose statistical analysis . A total 30 array need sample group . In study , investigator pose three question : 1 ) How many type miRNAs endometrium ovarian stimulation ? This identify miRNAs associate target gene relevant endometrium receptivity ; 2 ) Do level miRNA expression change luteal phase , window implantation ? This examine dynamic miRNAs associate remodel process endometrium ; 3 ) Do luteal phase support alter miRNA expression luteal phase ? This investigate steroid effect miRNA regulation . The investigator hypothesize many critical gene relate implantation regulate miRNAs . This research effort potentially advance knowledge endometrial characteristic COS impact sex steroid supplementation . Overall study help well understand genetic control implantation . Completion study may also provide measurable scientific evidence useful information management IVF cycle .</brief_summary>
	<brief_title>Endometrial Luteal Phase Characteristics Luteal Phase Support Controlled Ovarian Stimulation Protocols With GnRH Antagonists : Focusing MicroRNA</brief_title>
	<detailed_description />
	<criteria>21 31 year age female underwent standard screen protocol oocyte donation , accordance recommendation American Society Reproductive Medicine . Women body mass index exceed 28 kg/m2 , history : pelvic inflammatory disease , sexually transmit disease , reproductive tract pathology , systemic disease condition</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>31 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>miRNA endometrium</keyword>
</DOC>